Table 1 Baseline characteristics of the study population
All patients, n = 40 | Control group, n = 20 | Treatment group, n = 20 | P value | |
|---|---|---|---|---|
Age, years | 69 (51–76) | 67 (53–75) | 73 (49–77) | 0.892 |
Female sex, n (%) | 15 (38) | 7 (35) | 8 (40) | 1.0 |
BMI | 26 (24–28) | 27 (24–29) | 24 (23–26) | 0.100 |
SAPS2 | 51 ± 16 | 47 ± 16 | 56 ± 14 | 0.055 |
PaO2/FiO a2 | 228 ± 94 | 214 ± 90 | 241 ± 99 | 0.375 |
PEEPa, cmH2O | 10 (8–10) | 10 (8–12) | 9 (8–10) | 0.104 |
Reason for admission, n (%) | 0.112 | |||
Medical | 28 (70) | 11 (55) | 17 (85) | |
Elective surgery | 5 (12) | 4 (20) | 1 (5) | |
Emergency surgery | 7 (18) | 5 (25) | 2 (10) | |
ETT size, mm ID | 7.5 (7.5–7.5) | 7.5 (7.5–8.0) | 7.5 (7.5–7.5) | 0.113 |
Suspect of pneumonia, n (%) | 13 (32) | 6 (30) | 7 (35) | 1.0 |
ARDS diagnosis, n (%) | 6 (15) | 5 (25) | 1 (5) | 0.182 |